Polynovo Ltd
ASX:PNV

Watchlist Manager
Polynovo Ltd Logo
Polynovo Ltd
ASX:PNV
Watchlist
Price: 2.07 AUD 0.49% Market Closed
Market Cap: 1.4B AUD
Have any thoughts about
Polynovo Ltd?
Write Note

Polynovo Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Polynovo Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Polynovo Ltd
ASX:PNV
Cash & Cash Equivalents
AU$45.9m
CAGR 3-Years
81%
CAGR 5-Years
27%
CAGR 10-Years
55%
Nanosonics Ltd
ASX:NAN
Cash & Cash Equivalents
AU$23.5m
CAGR 3-Years
1%
CAGR 5-Years
13%
CAGR 10-Years
15%
SDI Ltd
ASX:SDI
Cash & Cash Equivalents
AU$6.3m
CAGR 3-Years
-16%
CAGR 5-Years
-1%
CAGR 10-Years
5%
Anteris Technologies Ltd
ASX:AVR
Cash & Cash Equivalents
AU$30.8m
CAGR 3-Years
94%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Ansell Ltd
ASX:ANN
Cash & Cash Equivalents
$185.5m
CAGR 3-Years
-7%
CAGR 5-Years
-14%
CAGR 10-Years
-5%
L
Lumos Diagnostics Holdings Ltd
ASX:LDX
Cash & Cash Equivalents
$6.5m
CAGR 3-Years
-48%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

Polynovo Ltd
Glance View

Market Cap
1.4B AUD
Industry
Health Care

Polynovo Ltd. engages in the provision biodegradable medical devices. The company is headquartered in Melbourne, Victoria and currently employs 122 full-time employees. The Company’s principal activity is the development of medical devices for various applications. The Company’s products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM is a man-made synthetic polymer that does not contain any biologic materials. BTM is a skin treatment. NovoSorb is a polymer, which is utilizes for the manufacture of novel medical devices, such as Biocompatible polymers. These biocompatible polymers are designed to support different functions of the body and then biodegrade into by-products that can be absorbed and excreted by the body. The company can be produced in a range of formats with different mechanical and degradation properties. In addition to NovoSorb BTM, they can be used for thermoplastic extrusions, filaments for weaving or knitting and as a solution for spray or dip coatings of other devices.

PNV Intrinsic Value
0.85 AUD
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Polynovo Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
45.9m AUD

Based on the financial report for Jun 30, 2024, Polynovo Ltd's Cash & Cash Equivalents amounts to 45.9m AUD.

What is Polynovo Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
55%

Over the last year, the Cash & Cash Equivalents growth was -2%. The average annual Cash & Cash Equivalents growth rates for Polynovo Ltd have been 81% over the past three years , 27% over the past five years , and 55% over the past ten years .

Back to Top